Key result
This editorial discusses new devices and drugs aimed at preventing restenosis and acute complications following coronary interventions.
Answers are grounded in this paper and cite their sources.
This editorial discusses promising solutions for preventing restenosis and acute complications following coronary interventions.
Interventions aimed at opening occluded coronary arteries continue to evolve. Two fundamental problems that limit the clinical efficacy of coronary interventions are restenosis after coronary angioplasty or atherectomy,13 reported since the early days of interventional cardiology, and acute complications from the intervention, such as coronary-artery dissection, acute or threatened vessel closure, and distal embolization.4,5 Both problems are the result of injury to the arterial wall. Attempts at solving these problems have involved the development of new devices and drugs. Two of the most promising solutions are described in this issue of the Journal.6,7 Preventing RestenosisDespite . . .
No takes yet. Share an insight, caveat, or question.
David R. Holmes (1997) conducted an editorial in Coronary restenosis and complications. This editorial discusses new devices and drugs aimed at preventing restenosis and acute complications following coronary interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: